研究方案:药物协调员对患者药物治疗质量的影响 (MEDCOOR) -随机对照试验
Maja Schlünsen1,2, Trine Graabæk3, Andreas Kristian Pedersen4
1The Hospital Pharmacy Research Unit, University Hospital of Southern Denmark, Aabenraa, Denmark.
PloS one
|November 26, 2024
概括
一项新的研究表明,涉及药物协调员可以提高护理过渡期间的药物安全性. 这种干预措施通过加强医院和全科医生之间的沟通来减少可能不合适的药物.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 患者安全 患者安全
- 临床药房 临床药房
背景情况:
- 由于信息流的碎片化,在医疗保健过渡期间,患者的安全往往会受到损害.
- 对全科医生进行药物变化的有效沟通对于预防不良药物事件至关重要.
- 个性化药物管理对患者至关重要,特别是在护理环境之间过渡时.
研究的目的:
- 评估药物协调员和"我的药物计划"对住院后药物安全性的影响.
- 评估医院和全科医生之间改善沟通对潜在不合适药物的影响.
- 调查这种干预对患者报告结果和再入院率的影响.
主要方法:
- 一项随机对照试验,涉及70名来自内分泌和脏病学部门的患者.
- 干预组接受了药物审查,并在向全科医生发送的电子释放信中提出了修改建议.
- 对照组接受了标准护理;主要结果是潜在不合适药物的比例.
主要成果:
- 该研究旨在确定出院后潜在不适合药物的比例.
- 二次结果包括生活质量,药物负担和患者再入院率.
- 该干预措施的重点是促进药物审查和向全科医生进行明确的沟通.
结论:
- 这种复杂的干预措施旨在减少与医院后药物使用相关的风险.
- 加强医院护理,患者和全科医生之间的沟通是提高药物安全的关键.
- 预计这些发现将有助于在护理过渡期间更安全的药物治疗实践.
更多相关视频
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.9K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
相关概念视频
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K